Advertisement
REVIEW ARTICLE| Volume 102, ISSUE 8, P1606-1613, August 2021

Download started.

Ok

Tools to Assess the Risk of Bias and Reporting Quality of Randomized Controlled Trials in Rehabilitation

      Abstract

      Objectives

      (1) To determine whether new tools and items have been developed to evaluate the risk of bias (RoB) and reporting of randomized controlled trials (RCTs) in rehabilitation; (2) to determine which items are included in the existing reporting guidelines, and to create a matrix of items to report and conduct trials in rehabilitation as the first step for a starting a rigorous validation process.

      Data Sources

      Searches were conducted in MEDLINE, EMBASE, and Cumulative Index to Nursing and Allied Health databases.

      Study Selection

      Studies should describe a newly developed tool to evaluate the RoB or quality of reporting for RCTs in the area of rehabilitation.

      Data extraction

      (1) First, we extracted items from new tools identified by the electronic search strategies and then (2) we looked at the items provided by the Consolidated Standards of Reporting Trials statement and its relevant extensions. We determined whether these items were already included in our matrix of items. Items were classified based on methodological domains they accomplish, biases they were able to target, and whether they guide reporting or conduct.

      Data Synthesis

      Among the 1596 citations found, 23 articles were potentially relevant. From these, only 3 new scales (National Institute for Complementary Medicine Acupuncture Network, Quality of reports on spa and balneotherapy [SPAC], Assessment of Study Quality and Reporting in Exercise) were found. In addition, the newly updated Cochrane RoB tool (RoB 2.0) was included. Our matrix contained 122 unique items for any rehabilitation area, 46 items (37.7%) were related to conduct, and 58 (47.5%) were related to the reporting; 18 (14.8%) were related to both. Overall, 76 new items were added among all domains.

      Conclusions

      Many individual and diverse items have been used to guide the reporting and conduct of rehabilitation trials. This indicates a great variability in number of items and an apparent lack of consensus on a core set of items to be used in rehabilitation. Future research should look into developing a core set of items for the rehabilitation field.

      Keywords

      List of abbreviations:

      CONSORT (Consolidated Standards of Reporting Trials), EXT (pragmatic trials: Extension - Pragmatic Trials), EXT-NPT (Extension - Nonpharmacologic Treatments), EXT-SPI (Extension - Social and Psychological Interventions), EXT- N-of-1-trial (Extension - one trial), NICMAN (National Institute for Complementary Medicine Acupuncture Network), RCT (randomized controlled trial), RCTRACK (Randomized Controlled Trial Rehabilitation Checklist), RoB (risk of bias), SPAC (Quality of Reports on Spa and Balneotherapy), TIDieR (Template for Intervention Description and Replication)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Archives of Physical Medicine and Rehabilitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Armijo-Olivo S
        • Fuentes CJ
        • Ospina M
        • Saltaji H
        • Hartling L
        Inconsistency in the items included in tools used in general health research and physical therapy to evaluate the methodological quality of randomized controlled trials: a descriptive analysis.
        BMC Med Res Methodol. 2013; 13: 1-19
        • Armijo-Olivo S
        • Macedo LG
        • Gadotti IC
        • Fuentes J
        • Stanton T
        • Magee DJ
        Scales to assess the quality of randomized controlled trials: a systematic review.
        Phys Ther. 2008; 88: 156-175
        • Higgins JPT
        • Altman DG
        • Goetzsche PC
        • et al.
        The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
        BMJ. 2011; 343: d5928
        • Albanese E
        • Butikofer L
        • Armijo-Olivo S
        • Ha C
        • Egger M
        Construct validity of the Physiotherapy Evidence Database (PEDro) quality scale for randomized trials: item response theory and factor analyses.
        Res Synth Methods. 2020; 11: 227-236
        • Savović J
        • Weeks L
        • Sterne JA
        • et al.
        Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation.
        Syst Rev. 2014; 3: 37
        • Hartling L
        • Ospina M
        • Liang Y
        • et al.
        Risk of bias versus quality assessment of randomised controlled trials: cross sectional study.
        BMJ. 2009; 339: 1017
        • Hartling L
        • Hamm MP
        • Milne A
        • et al.
        Testing the Risk of Bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs.
        J Clin Epidemiol. 2012; 66: 973-981
        • Armijo-Olivo S
        • Ospina M
        • da Costa BR
        • et al.
        Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane Risk of Bias Tool in physical therapy trials.
        PLoS One. 2014; 9: e96920
        • Armijo-Olivo S
        • Stiles CR
        • Hagen NA
        • Biondo PD
        • Cummings GG
        Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research.
        J Eval Clin Pract. 2012; 18: 12-18
        • Negrini S
        • Armijo-Olivo S
        • Patrini M
        • et al.
        The Randomized Controlled Trials Rehabilitation Checklist: methodology of development of a reporting guideline specific to rehabilitation.
        Am J Phys Med Rehabil. 2020; 99: 210-215
        • Moher D
        • Liberati A
        • Tetzlaff J
        • et al.
        Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement.
        Ann Intern Med. 2009; 151: 264-269
        • Sterne JA
        • Savovic J
        • Page MJ
        • et al.
        RoB 2: a revised tool for assessing risk of bias in randomised trials.
        BMJ. 2019; 366: l4898
        • Meyer T
        • Selb M
        • Kiekens C
        • et al.
        Toward better reporting standards of patients’ characteristics in rehabilitation trials: applying a new conceptual framework to current standards.
        Am J Phys Med Rehabil. 2020; 99: 216-223
        • Boutron I
        • Altman DG
        • Moher D
        • Schulz KF
        • Ravaud P
        • Group CN
        CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts.
        Ann Intern Med. 2017; 167: 40-47
        • Grant S
        • Mayo-Wilson E
        • Montgomery P
        • et al.
        CONSORT-SPI 2018 explanation and elaboration: guidance for reporting social and psychological intervention trials.
        Trials. 2018; 19: 406
        • Zwarenstein M
        • Treweek S
        • Gagnier JJ
        • et al.
        Improving the reporting of pragmatic trials: an extension of the CONSORT statement.
        BMJ. 2008; 337: a2390
        • Vohra S
        • Shamseer L
        • Sampson M
        • et al.
        CONSORT extension for reporting N-of-1 trials (CENT) 2015 statement.
        J Clin Epidemiol. 2016; 76: 9-17
        • Hoffmann TC
        • Glasziou PP
        • Boutron I
        • et al.
        Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
        BMJ. 2014; 348: g1687
        • Yamato T
        • Maher C
        • Saragiotto B
        • et al.
        The TIDieR checklist will benefit the physiotherapy profession.
        Physiother Theory Pract. 2017; 33: 267-268
        • Schulz KF
        • Altman DG
        • Moher D
        CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
        BMJ. 2010; 340: 698-702
        • Moher D
        • Jadad AR
        • Nichol G
        • Penman M
        • Tugwell P
        • Walsh S
        Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists.
        Control Clin Trials. 1995; 16: 62-73
        • Delgado-Rodriguez M
        • Llorca J
        Bias.
        J Epidemiol Community Health. 2004; 58: 635-641
        • Sackett DL
        Bias in analytic research.
        J Chronic Dis. 1979; 32: 51-68
        • Viswanathan M
        • Berkman ND
        Development of the RTI item bank on risk of bias and precision of observational studies.
        Journal of Clinical Epidemiology. 2012; 65: 163-178
        • Kamioka H
        • Kawamura Y
        • Tsutani K
        • et al.
        A checklist to assess the quality of reports on spa therapy and balneotherapy trials was developed using the Delphi consensus method: the SPAC checklist.
        Complement Ther Med. 2013; 21: 324-332
        • Smart NA
        • Waldron M
        • Ismail H
        • et al.
        Validation of a new tool for the assessment of study quality and reporting in exercise training studies: TESTEX.
        Int J Evid Based Healthc. 2015; 13: 9-18
        • Smith CA
        • Zaslawski CJ
        • Cochrane S
        • et al.
        Reliability of the NICMAN Scale: an instrument to assess the quality of acupuncture administered in clinical trials.
        Evid Based Complement Alternat Med. 2017; 20175694083
        • Negrini S
        • Arienti C
        • Pollet J
        • et al.
        Clinical replicability of rehabilitation interventions in randomized controlled trials reported in main journals is inadequate.
        J Clin Epidemiol. 2019; 114: 108-117
        • Wears RL
        Standardisation and its discontents.
        Cogn Technol Work. 2015; 17: 89-94
        • Slade SC
        • Dionne CE
        • Underwood M
        • Buchbinder R
        Consensus on Exercise Reporting Template (CERT): explanation and elaboration statement.
        Br J Sports Med. 2016; 50: 1428-1437
        • Slade SC
        • Dionne CE
        • Underwood M
        • et al.
        Consensus on Exercise Reporting Template (CERT): modified Delphi study.
        Phys Ther. 2016; 96: 1514-1524
        • Levack WM
        • Engkasan JP
        • Heinemann AW
        • Negrini S
        A review of CONSORT guidelines about comparison groups with a focused discussion on implications for rehabilitation clinical trials.
        Am J Phys Med Rehabil. 2020; 99: 191-197
        • Abdul Latif L
        • Daud Amadera JE
        • Pimentel D
        • Pimentel T
        • Fregni F
        Sample size calculation in physical medicine and rehabilitation: a systematic review of reporting, characteristics, and results in randomized controlled trials.
        Arch Phys Med Rehabil. 2011; 92: 306-315
        • Castellini G
        • Gianola S
        • Bonovas S
        • Moja L
        Improving power and sample size calculation in rehabilitation trial reports: a methodological assessment.
        Arch Phys Med Rehabil. 2016; 97: 1195-1201
        • Copsey B
        • Thompson JY
        • Vadher K
        • et al.
        Sample size calculations are poorly conducted and reported in many randomized trials of hip and knee osteoarthritis: results of a systematic review.
        J Clin Epidemiol. 2018; 104: 52-61
        • Schulz KF
        • Grimes DA
        Allocation concealment in randomised trials: defending against deciphering.
        Lancet. 2002; 359: 614-618
        • Armijo-Olivo S
        • Fuentes J
        • da Costa BR
        • Saltaji H
        • Ha C
        • Cummings GG
        Blinding in physical therapy trials and its association with treatment effects: a meta-epidemiological study.
        Am J Phys Med Rehabil. 2017; 96: 34-44
        • Armijo-Olivo S
        • Saltaji H
        • da Costa BR
        • Ha C
        • Fuentes CJ
        • Cummings G
        What is the influence of randomization sequence generation and allocation concealment on treatment effects of physical therapy trials? A meta-epidemiological study.
        BMJ Open. 2015; 5e008562
        • Bauchner H
        • Golub RM
        • Fontanarosa PB
        Reporting and interpretation of randomized clinical trials.
        JAMA. 2019; 322: 732-735
        • Mokkink LB
        • Terwee CB
        • Patrick DL
        • et al.
        The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.
        Qual Life Res. 2010; 19: 539-549
        • Terwee CB
        • Mokkink LB
        • Knol DL
        • Ostelo RW
        • Bouter LM
        • de Vet HC
        Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist.
        Qual Life Res. 2012; 21: 651-657
        • Page MJ
        • Higgins JP
        • Clayton G
        • Sterne JA
        • Hróbjartsson A
        • Savović J
        Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies.
        PLoS One. 2016; 11e0159267
        • Armijo-Olivo S
        • da Costa BR
        • Cummings GG
        • et al.
        PEDro or Cochrane to assess the quality of clinical trials? A meta-epidemiological study.
        PLoS One. 2015; 10e0132634
        • Moher D
        • Pham B
        • Jones A
        • et al.
        Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?.
        Lancet. 1998; 352: 609-613
        • Nuesch E
        • Reichenbach S
        • Trelle S
        • et al.
        The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study.
        Arthritis Rheum. 2009; 61: 1633-1641
        • Nuesch E
        • Trelle S
        • Reichenbach S
        • et al.
        The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study.
        BMJ. 2009; 339: 679-683
        • Nuesch E
        • Trelle S
        • Reichenbach S
        • et al.
        Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study.
        BMJ. 2010; 341: 241
        • Wood L
        • Egger M
        • Gluud LL
        • et al.
        Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.
        BMJ. 2008; 336: 601-605
        • Bolvig J
        • Juhl CB
        • Boutron I
        • et al.
        Some Cochrane risk-of-bias items are not important in osteoarthritis trials: a meta-epidemiological study based on Cochrane Reviews.
        J Clin Epidemiol. 2018; 95: 128-136